AOD-9604 — Research Background

AOD-9604 was originally developed as an anti-obesity drug candidate. As a fragment of hGH, it retains the fat-metabolizing properties of the full growth hormone molecule without the associated growth-promoting effects. It has been studied in the context of adipose tissue regulation, lipid metabolism, and body composition research.

Clinical Applications

• MedSpas & Aesthetic Clinics: The primary growth area for AOD-9604 in Europe. Body composition optimization protocols in aesthetic medicine settings.
• Metabolic Health Clinics: Researched alongside GLP-1 compounds and metabolic health protocols.
• Longevity Programs: Used in body composition components of broader anti-aging protocols.
• Sports Medicine: Fat metabolism and body composition in athletic performance research contexts.

Market Opportunity

AOD-9604 is one of the fastest-growing research peptides in European aesthetic medicine. The compound benefits from the broader growth of body-composition and metabolic health programs in MedSpas, driven by increased interest in GLP-1 alternatives and weight management protocols.